Stéphane Bancel speaking at Endpoints @ #JPM20 (Photo: Jeff Rumans for Endpoints News)
January 31, 2022 01:51 PM ESTUpdated 02:12 PM
Bioregnum
Pharma
FDA+

The FDA ap­proves Mod­er­na's rev­o­lu­tion­ary new Covid-19 vac­cine. What took so long?

Mod­er­na just picked up its first-ever full BLA ap­proval for its cel­e­brat­ed Covid-19 vac­cine, and did it at what most every­one in the busi­ness would …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

A service from the Financial Times